Genentech Financial Market Data
| Last Close 28-Aug-2008 |
$98.45 |
Price/ Sales Ratio |
8.49 |
| 52-Week High |
$99.14 |
Price/ Book Ratio |
7.78 |
| 52-Week Low |
$65.35 |
Price/ Earnings Ratio |
33.41 |
| 60-Month Beta |
(0.3) |
Price/ Cash Flow Ratio |
34.35 |
| Market Cap (mil.) |
$103,928.7 |
Return on Assets |
17.4% |
| Shares Outstanding (mil.) |
1,055.7 |
Return on Equity |
25.5% |
| Dividend Rate |
-- |
Current Ratio |
3.35 |
| Dividend Yield |
-- |
Long-Term Debt/Equity |
0.23 |
| # of Institutional Holders |
782 |
% Owned by Institutions |
37.0% |
| Latest Short Interest Ratio |
1.12 |
Latest Net Insider Transactions |
-- |
| Revenue Growth |
11.2% |
121.1% |
305.5% |
| EPS Growth |
17.7% |
205.2% |
551.1% |
| Dividend Growth |
0.0% |
0.0% |
0.0% |
This data is provided as per license from EDGAR Online
